Considering that insulin and metformin are frequently used as pharmacotherapy in pregnant women with GDM, we wanted to evaluate the effect of both hypoglycemics on the synthesis of pro-inflammatory cytokines in human placenta. The gene discussed is INS; the disease is gestational diabetes.